Syntax for Science, S.L
10
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
1 terminated/withdrawn out of 10 trials
83.3%
-3.2% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH)
Role: collaborator
A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer
Role: collaborator
Spanish Real-World Evidence Cabozantinib
Role: collaborator
A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Role: collaborator
Nalirinox Neo-pancreas RAS Mut ctDNA Study
Role: collaborator
A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours
Role: collaborator
Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage
Role: collaborator
Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19
Role: collaborator
A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
Role: collaborator
Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury
Role: collaborator
All 10 trials loaded